Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124274) titled 'Efficacy and Safety of Myocardial Peptide in Patients with Sepsis-Induced Left Ventricular Systolic Dysfunction: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Exploratory Study' on May 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Condition:
left ventricular systolic dysfunction in patients with sepsis
Intervention:
Control group:Myocardial Peptide Mimetic plus Standard Therapy
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-06-01
Target Sample Size: Control group:1...